CD209 and infection: Phorbol 12-myristate 13-acetate (PMA)-treatment increased the expression of DC-SIGN, but not DC-SIGNR nor LSECtin, and enhanced the infection of THP-1 cells by iVLP-GP(Ori) (Fig 5A and 5B).